Deep Birjani

Mr. Deep Birjani

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AAAyesha Ahmed
Ayesha Ahmed
DBDeep Birjani
Deep Birjani
MAMaryam Ahmed
Maryam Ahmed
UIUnaisa - Ishaque
Unaisa - Ishaque
ZSZafir Ashar Siddiqui
Zafir Ashar Siddiqui
MKMuhammad Sameer Khan
Muhammad Sameer Khan
Pneumonia and malnutrition are major contributors to mortality among older adults, yet their combined population-level burden remains poorly defined. We examined national trends and sociodemographic disparities in pneumonia and malnutrition-associated mortality among adults aged 65 years and older in the United States by analyzing data from the CDC WONDER Multiple Cause of Death database from 1999 to 2020. Age-adjusted mortality rates (AAMR) per 100,000 population were calculated, and temporal trends were assessed using Joinpoint regression. Between 1999 and 2020, 81,753 deaths involving both conditions occurred. The overall AAMR declined from 13.82 to 11.90 per 100,000, though a sharp increase occurred from 2017 to 2020. Mortality rates were higher among males, adults aged 85 and older, American Indian/Alaska Native and Black individuals, nonmetropolitan populations, and residents in the South, with Texas exhibiting the highest state-level rate. Pneumonia and malnutrition-associated mortality among older U.S. adults declined over much of the study period but increased substantially in recent years. Persistent demographic and geographic disparities suggest that vulnerable older adults remain at elevated risk, highlighting the need for integrated pneumonia prevention, nutritional screening, and targeted early interventions.

25 February 2026 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
MSMuhammad Yousuf Saleem
Muhammad Yousuf Saleem
MMMuhammad Salman Mustafa
Muhammad Salman Mustafa
ASAreeba Shafiq
Areeba Shafiq
SKSameer Khan
Sameer Khan
MRMudassir Rauf
Mudassir Rauf
JAJazza Aamir
Jazza Aamir
Background: Disseminated intravascular coagulation (DIC) is a severe, life-threatening coagulopathy often secondary to infection, malignancy, or obstetric complications. Despite advances in critical care, national patterns and disparities in DIC-related mortality remain underexplored. Objectives: To examine temporal, demographic, and regional trends in DIC-related mortality among U.S. adults from 1999 to 2020. Methods: Death certificate data were obtained from the CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) database for adults aged ≥ 25 years with DIC listed as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population and annual percent change (APC) were calculated using Joinpoint regression and stratified by sex, race/ethnicity, age group, urbanization, and region. Results: From 1999 to 2020, 71,241 DIC-related deaths were identified among U.S. adults. The overall AAMR declined from 2.1 per 100,000 in 1999 to 1.6 in 2020. Men had higher mortality than women (1.6 vs. 1.5), and non-Hispanic (NH) Black adults had the highest AAMR (2.8), followed by Hispanic (1.6), and NH White adults (1.4). Mortality was highest among adults ≥ 85 years (6.1), residents of nonmetropolitan areas (1.6), and those in the South (1.6) and Northeast regions (1.5). Conclusions: Following a prolonged decline, DIC-related mortality in U.S. adults has risen since 2017, particularly among men, Black adults, and those in the South and rural areas. Targeted prevention and equitable access to critical care are essential to curb this resurgence.

20 August 2026 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
ACAsad Ali Ahmed Cheema
Asad Ali Ahmed Cheema
RAReshail Asif
Reshail Asif
UAUnsa Arif
Unsa Arif
MMManahil Malik
Manahil Malik
SMSarah Misbah
Sarah Misbah
AGAbu Huraira Bin Gulzar
Abu Huraira Bin Gulzar
Aims: Pulsed field ablation (PFA) is a non‐thermal alternative to conventional thermal ablation for paroxysmal atrial fibrillation (AF). We conducted an updated systematic review and meta‐analysis of randomized evidence comparing efficacy, safety, and procedural outcomes. Methods: PubMed/MEDLINE and the Cochrane Central Register of Controlled Trials were searched from inception through March 2026 for randomized controlled trials (RCTs) comparing PFA with thermal ablation in adults undergoing first catheter ablation for paroxysmal AF. Risk ratios (RRs) or mean differences (MDs) with 95% confidence intervals (CIs) were pooled using random‐effects models. Results: Four RCTs enrolling 1 393 patients were included. PFA showed no statistically detectable difference in 12‐month treatment success (RR, 1.04; 95% CI, 0.97 to 1.12; I 2 = 7%), recurrent atrial arrhythmias (RR, 1.00; 95% CI, 0.77 to 1.29; I 2 = 42%), or composite serious adverse events (RR, 0.71; 95% CI, 0.32 to 1.57; I 2 = 7%). PFA shortened procedure time (MD, −22.42 min; 95% CI, −33.44 to −11.39; I 2 = 91%) and LA dwell time (MD, −25.73 min; 95% CI, −34.66 to −16.79; I 2 = 92%), but increased fluoroscopy time (MD, 7.34 min; 95% CI, 0.39 to 14.30; I 2 = 98%). Conclusions: Across the included trial configurations, 12‐month efficacy estimates did not differ detectably. Sparse safety events and wide confidence intervals precluded equivalence claims. Pooled procedure and LA dwell times favored PFA, but platform, comparator, and workflow heterogeneity limit generalizability. Procedural findings are exploratory and should not be interpreted as direct energy‐specific effects.